English
Montpellier, France, July 2024. SurgiMab is proud to announce the participation of Françoise Cailler, CEO & CSO, at the prestigious World Molecular Imaging Congress (WMIC2024) to be held in Montreal from September 9 to 14, 2024 https://wmis.org/wmic-2024-about/.
WMIC is a leading international conference dedicated to advances in molecular imaging, bringing together scientists, researchers and healthcare professionals from around the world. Françoise Cailler will present SurgiMab’s innovations in targeted imaging agents for fluorescence-guided surgery during the OSN (Optical Surgical Navigation) group session on September 10 https://wmis.org/wmic1/osn-2024/ .
“It’s an honor to represent SurgiMab at WMIC2024 and to share our advances with the international scientific community,” says Françoise Cailler. “We are convinced that our innovations will transform the way surgeons approach cancer treatment. This group brings together researchers, clinicians and industry representatives, and offers us a perfect opportunity, within the WMIC2024 congress, to strengthen our collaborations and discover emerging trends from experts in the clinical and regulatory fields.”
To see the conference program, please follow this link.Don’t hesitate to get in touch to schedule a face to face meeting with Françoise : fcailler(@)surgimab.com